Wells Fargo Downgrades Inari Medical to Equal-Weight, Raises Price Target to $80

Benzinga · 01/07 20:02
Wells Fargo analyst Larry Biegelsen downgrades Inari Medical (NASDAQ:NARI) from Overweight to Equal-Weight and raises the price target from $65 to $80.